Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway

被引:194
作者
Jeffers, M
Taylor, GA
Weidner, KM
Omura, S
VandeWoude, GF
机构
[1] NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,FREDERICK,MD 21702
[2] MAX DELBRUCK CTR MOL MED,D-13125 BERLIN,GERMANY
[3] KITASATO INST,BIOL FUNCT RES CTR,TOKYO 108,JAPAN
关键词
D O I
10.1128/MCB.17.2.799
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Met tyrosine kinase receptor is a widely expressed molecule which mediates pleiotropic cellular responses following activation by its ligand, hepatocyte growth factor/scatter factor (HGF/SF). In this communication we demonstrate that significant Met degradation is induced by HGF/SF and that this degradation can be blocked by lactacystin, an inhibitor of proteasome activity. We also show that Met is rapidly polyubiquitinated in response to ligand and that polyubiquitinated Met molecules, which are normally unstable, are stabilized by lactacystin. Both HGF/SF-induced degradation and polyubiquitination of Met were shown to be dependent on the receptor possessing intact tyrosine kinase activity. Finally, we found that a normally highly labile 55-kDa fragment of the Met receptor is stabilized by lactacystin and demonstrate that it represents a cell-associated remnant that is generated following the ligand-independent proteolytic cleavage of the Met receptor in its extracellular domain. This truncated Met molecule encompasses the kinase domain of the receptor and is itself tyrosine phosphorylated. We conclude that the ubiquitin-proteasome pathway plays a significant role in the degradation of the Met tyrosine kinase receptor as directed by ligand-dependent and -independent signals. We propose that this proteolytic pathway may be important for averting cellular transformation by desensitizing Met signaling following ligand stimulation and by eliminating potentially oncogenic fragments generated via extracellular cleavage of the Met receptor.
引用
收藏
页码:799 / 808
页数:10
相关论文
共 68 条
[1]   ESSENTIAL ROLE FOR THE C-MET RECEPTOR IN THE MIGRATION OF MYOGENIC PRECURSOR CELLS INTO THE LIMB BUD [J].
BLADT, F ;
RIETHMACHER, D ;
ISENMANN, S ;
AGUZZI, A ;
BIRCHMEIER, C .
NATURE, 1995, 376 (6543) :768-771
[2]   IDENTIFICATION OF THE HEPATOCYTE GROWTH-FACTOR RECEPTOR AS THE C-MET PROTOONCOGENE PRODUCT [J].
BOTTARO, DP ;
RUBIN, JS ;
FALETTO, DL ;
CHAN, AML ;
KMIECIK, TE ;
VANDEWOUDE, GF ;
AARONSON, SA .
SCIENCE, 1991, 251 (4995) :802-804
[3]   HEPATOCYTE GROWTH-FACTOR SCATTER FACTOR INDUCES A VARIETY OF TISSUE-SPECIFIC MORPHOGENIC PROGRAMS IN EPITHELIAL-CELLS [J].
BRINKMANN, V ;
FOROUTAN, H ;
SACHS, M ;
WEIDNER, KM ;
BIRCHMEIER, W .
JOURNAL OF CELL BIOLOGY, 1995, 131 (06) :1573-1586
[4]  
BRIZZI MF, 1994, ONCOGENE, V9, P1583
[5]   HEPATOCYTE GROWTH-FACTOR IS A POTENT ANGIOGENIC FACTOR WHICH STIMULATES ENDOTHELIAL-CELL MOTILITY AND GROWTH [J].
BUSSOLINO, F ;
DIRENZO, MF ;
ZICHE, M ;
BOCCHIETTO, E ;
OLIVERO, M ;
NALDINI, L ;
GAUDINO, G ;
TAMAGNONE, L ;
COFFER, A ;
COMOGLIO, PM .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :629-641
[6]   THE ROLE OF KINASE-ACTIVITY AND THE KINASE INSERT REGION IN LIGAND-INDUCED INTERNALIZATION AND DEGRADATION OF THE C-FMS PROTEIN [J].
CARLBERG, K ;
TAPLEY, P ;
HAYSTEAD, C ;
ROHRSCHNEIDER, L .
EMBO JOURNAL, 1991, 10 (04) :877-883
[7]   THE UBIQUITIN-PROTEASOME PROTEOLYTIC PATHWAY [J].
CIECHANOVER, A .
CELL, 1994, 79 (01) :13-21
[8]  
CREPALDI T, 1994, J BIOL CHEM, V269, P1750
[9]   MAKE IT OR BREAK IT - THE ROLE OF UBIQUITIN-DEPENDENT PROTEOLYSIS IN CELLULAR-REGULATION [J].
DESHAIES, RJ .
TRENDS IN CELL BIOLOGY, 1995, 5 (11) :428-434
[10]   LIGAND AND PROTEIN KINASE-C DOWNMODULATE THE COLONY-STIMULATING FACTOR-I RECEPTOR BY INDEPENDENT MECHANISMS [J].
DOWNING, JR ;
ROUSSEL, MF ;
SHERR, CJ .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (07) :2890-2896